Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INWK

InnerWorkings (INWK) Stock Price, News & Analysis

InnerWorkings logo

About InnerWorkings Stock (NASDAQ:INWK)

Advanced Chart

Key Stats

Today's Range
$2.99
$2.99
50-Day Range
$2.83
$3.00
52-Week Range
$0.87
$5.81
Volume
N/A
Average Volume
489,347 shs
Market Capitalization
$158.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INWK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnerWorkings and its competitors with MarketBeat's FREE daily newsletter.

INWK Stock News Headlines

Learn more about what we do
Enova Announces New Board Member Lindsay Corby
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
HiBid Appoints Pat McCusker as Chief Executive Officer
Biology KS3 & KS4: The human eye
See More Headlines

INWK Stock Analysis - Frequently Asked Questions

InnerWorkings, Inc. (NASDAQ:INWK) announced its quarterly earnings data on Tuesday, June, 16th. The business services provider reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.00 by $0.04. The business services provider earned $261.36 million during the quarter, compared to analysts' expectations of $261.40 million. InnerWorkings had a negative net margin of 1.81% and a positive trailing twelve-month return on equity of 0.46%.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnerWorkings investors own include Adamis Pharmaceuticals (ADMP), Ampio Pharmaceuticals (AMPE), Cerecor (CERC), Allena Pharmaceuticals (ALNA), CTI BioPharma (CTIC), Genocea Biosciences (GNCA) and Rigel Pharmaceuticals (RIGL).

Company Calendar

Last Earnings
6/16/2020
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Business Services
Sub-Industry
Commercial Printing
Current Symbol
NASDAQ:INWK
CIK
1350381
Fax
N/A
Employees
2,100
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
21.36
P/E Growth
1.07
Net Income
-$10.07 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.16 billion
Cash Flow
$0.38 per share
Price / Cash Flow
7.82
Book Value
$3.42 per share
Price / Book
0.87

Miscellaneous

Free Float
N/A
Market Cap
$158.00 million
Optionable
Optionable
Beta
2.53
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:INWK) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners